Objectives: To evaluate in fetal aneuploidy screening the desirability of using Fetal Medicine Foundation (FMF) normal medians of nuchal translucency thickness (NT) measurements or performer-specific medians, and whether the NT measurements should be expressed as Delta-NT or Log NT-MoM values.
Settings: First trimester-combined screening programme in a low risk population in Flanders, Belgium (Algemeen Medisch Laboratorium, Antwerp).
Methods: Pregnancies unaffected by trisomy 21 (T21) were screened by FMF-trained or other ultrasonographers. Performer-specific NT medians were established for FMF-trained and other ultrasonographers. NCSS Statistical Software was used to establish probability plots for Log NT-MoM and Delta-NT values, relative to performer-specific references or to the FMF-reference.
Results: A total of 16,096 pregnancies were evaluated. Six FMF-trainees and five other ultrasonographers each performed between 83 and 658 NT measurements. For the FMF-trainees, FMF-specific NT-MoM medians were close to one at a crown-rump length (CRL) between 50 and 80 mm, whereas the population-specific NT-MoM medians of the other ultrasonographers were close to one at a CRL between 40 and 80 mm. Performer-specific Delta-NT values fitted a Gaussian distribution between the 5th and 90th percentiles, while for the Log NT-MoM values this was between the 10th and 95th percentiles.
Conclusion: We conclude that (i) the use of screening would benefit from performer-specific NT-medians based on Log NT-MoM values; (ii) the use of Log NT-MoM values is marginally better than the use of delta-NT MoMs; and (iii) NT measurements are valid at about 10 weeks (crown-rump length 40-45 mm) as well as at 11-13 weeks.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1258/096914106776179755 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prenatal ultrasound diagnosis and quality control of fetal nuchal translucency.
Zhong Nan Da Xue Xue Bao Yi Xue Ban
April 2024
Department of Obstetrics Ultrasonography Room, Xiangya Hospital, Central South University, Changsha 410008, China.
Objectives: In clinical ultrasound examinations, it is challenging to perform quality control on the images of each fetal nuchal translucency (NT) and crown-rump length (CRL). However, small measurement differences can increase the probability of false-positive or false-negative diagnosis. Therefore, it is necessary to establish a quality control system for fetal NT examination.
View Article and Find Full Text PDFUnited States' experience in nuchal translucency measurement: variation according to provider characteristics in over five million ultrasound examinations.
Ultrasound Obstet Gynecol
November 2021
Tel Aviv University, Faculty of Medicine, Ramat Aviv, Israel.
Objective: The Nuchal Translucency Quality Review (NTQR) program has provided standardized education, credentialing and epidemiological monitoring of nuchal translucency (NT) measurements since 2005. Our aim was to review the effect on NT measurement of provider characteristics since the program's inception.
Methods: We evaluated the distribution of NT measurements performed between January 2005 and December 2019, for each of the three primary performance indicators of NT measurement (NT median multiples of the median (MoM), SD of log NT MoM and slope of NT with respect to crown-rump length (CRL)) for all providers within the NTQR program with more than 30 paired NT/CRL results.
Do the Levels of Maternal Plasma Trace Elements Affect Fetal Nuchal Translucency Thickness?
PLoS One
June 2016
Institute of Environmental and Occupational Health Sciences, School of Medicine, National Yang Ming University, Taipei, Taiwan.
Objective: Fetal nuchal translucency (NT) thickness is an important marker for prenatal screening; however, studies focusing on the correlation between maternal trace element levels and NT thickness are limited. The aim of this study was to evaluate maternal trace element levels during the first trimester and to investigate the association between maternal trace element levels and fetal NT thickness.
Methods: In total, 113 samples were obtained from singleton pregnant women.
Quality assurance of nuchal translucency for prenatal fetal Down syndrome screening.
J Matern Fetal Neonatal Med
July 2012
The Chinese University of Hong Kong, Obstetrics and Gynecology, Prince of Wales Hospital, Shatin, Hong Kong, China.
Objective: To assess the quality of nuchal translucency, (NT) measurements were performed at four public institutions performing routine first trimester combined prenatal screening for Down syndrome.
Methods: The median of the NT-MoM distribution and standard deviation (SD) of the log(10) NT-MoM were determined. Sonographers and screening centres distributions were assessed for measures of central tendency (median) and dispersion (log(10) SD).
Impact of nuchal translucency credentialing by the FMF, the NTQR or both on screening distributions and performance.
Ultrasound Obstet Gynecol
February 2012
Comprehensive Genetics & Department of Obstetrics & Gynecology, Mt Sinai School of Medicine, New York, NY 10065, USA.
Objective: In the USA, both The Fetal Medicine Foundation (FMF) and the Nuchal Translucency Quality Review Program (NTQR) have operated education, review and credentialing for physicians and sonographers for the measurement of nuchal translucency (NT). We sought to assess differences in the distribution of NT measurements based upon the system from which the operator obtained their education, review and credentialing.
Methods: 398 311 NT measurements by 1541 sonographers who had performed ≥ 50 exams from July 2008 to June 2010 were grouped by organization.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!